On the list of things that make my life worth living, I can now gladly add the experience of seeing “Every Brilliant Thing.”
Rob Weinert-Kendt
Rob Weinert-Kendt, an arts journalist and editor of American Theatre magazine, has written for The New York Times and Time Out New York.
‘How to Get to Heaven from Belfast’ can’t match the high-wire comedy of ‘Derry Girls’
“How to Get to Heaven From Belfast,” Lisa McGee’s new series for Netflix, is a wobbly, unsuccessful blend of comedy, mystery and would-be thriller.
‘Pluribus’ asks big questions about human freedom. It’s must-think TV.
‘Pluribus’ asks: Would we be willing to give up the struggles of the human condition for life in a friction-free bubble of contentment?
‘Liberation’ on Broadway jokes its way into hard truths about feminism
“Liberation” is, really, a play of ideas and argument, in the tradition of George Bernard Shaw or Tony Kushner.
In ‘Blue Moon,’ Ethan Hawke surprises as a melancholy Broadway legend
The new movie “Blue Moon,” named for one of Rodgers & Hart’s most enduring tunes, is set at the pivot between these two eras—from Jazz Age sass and Depression-era gloom to post-World War II patriotism and conformity.
In ‘Ragtime,’ the idea of a just, multiracial America is tragically incomplete
A new revival of ‘Ragtime’ plays like a dead-serious fable.
Why ‘Waiting for Godot’ is worth reviving—with Keanu Reeves and Alex Winter
This “Godot” is more brisk and playful than most, with one irresistible (if inadvisable) “Bill & Ted” reference.
Review: A new biography of Lin-Manuel Miranda tells his creative origin story
In his engaging new biography, ‘Lin-Manuel Miranda: The Education of an Artist,’ Daniel Pollack-Pelzner traces a career path that was hardly inevitable or solitary.
‘Saturday Church’ and ‘The Brothers Size’: Stories of Black queer spirituality
For queer Christians of any race, the church has too often felt not like a loving home but rather a house of judgment.
I’ve never loved medical shows. ‘The Pitt’ is different.
“The Pitt” often feels like it’s aiming to be the medical show to end all medical shows.
